What this means
Ageing with Health is a longitudinal cohort study aimed to examine trajectories of health, disability and wellbeing and their determinants for Spanish ageing population. The data that makes up the baseline was collected from a nationally representative sample of non-institutionalized adults as part of the "Collaborative Research on Aging in Europe (COURAGE in Europe)" project between July 2011 and May 2012.
A plain-English summary is on its way. Until then, this is the start of the registry's own summary.
- Status
- Completed
- Who can join
- Ages 18 and over
- Where
- 3 sites
The science
- Registered title
- Ageing and Health. Spanish Longitudinal Study
- Trial ID
- NCT03343886 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Health, Subjective, Disability, Evaluation, Chronic Disease, Mental Disorder, Aging, Loneliness, Cognitive Decline, Well-being
- Sponsor
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Ages
- 18 Years to no maximum
- Dates
- First posted Nov 17, 2017 · updated Oct 29, 2026
Registry summary
Ageing with Health is a longitudinal cohort study aimed to examine trajectories of health, disability and wellbeing and their determinants for Spanish ageing population. The data that makes up the baseline was collected from a nationally representative sample of non-institutionalized adults as part of the "Collaborative Research on Aging in Europe (COURAGE in Europe)" project between July 2011 and May 2012. The second wave was carried out as part of the "Age with Health" project between December 2014 and June 2015, and three years later, in 2018, the third wave was carried out. In 2019-2021, a new cohort of participants were brought in (2019 cohort), some of whom were interviewed again by telephone during the first Coronavirus (COVID-19) lockdown, in early 2020. In 2022, the fourth wave of the 2011 cohort was evaluated, and in 2023, the second wave of the 2019 cohort was evaluated. Finally, in 2025, the fifth wave of the 2011 cohort and the third wave of the 2019 cohort were evaluated, which are the last follow-ups in this study.
Sites (3)
- Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa, Madrid, Madrid, Spain
- Universidad Autónoma de Madrid, Madrid, Madrid, Spain